Manski S, Schmoyer C, Pang A, Lieberman J, Gernhardt M, Murugesan N, Leto A, Erwin R, Kavanagh T, Conn M. The Safety of the Re-opening of an Academic Medical Center Outpatient Endoscopy Unit During the COVID-19 Pandemic. , Gastroenterol Res., 15(4): 2022,200-206

Pang A, Halegoua-De Marzio DL, Sass DA, Shah AP, Singh P, Powers T, Ryan M, Fenkel J. (2022). Transplant Evaluation Practices for Kidney Donors and Recipients with History of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States. , Gastroenterology, 162(7): 2022,S-1293

Pang A, Boortalary T, Au C, Henry C, Infantolino A, Tofani C. The Effect of Weekend versus Weekday Admission on Outcomes of Suspected Small Bowel Bleeding. , Gastrointest Endosc, 95 (6): 2022

Hong SJ, Zenger C, Pecoriello J, Pang A, Vallely M, Hudesman DP, Chang S, Axelrad JE. Ustekinumab and Vedolizumab Are Not Associated with Subsequent Cancer in IBD Patients with Prior Malignancy. , Inflamm Bowel Dis., 28(12): 2022,1826-1832

Tapaskar N, Pang A, Werner DA, Sengupta N. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis. , Dig Dis Sci., 66(2): 2021,554-566.

Pang A, Chang S, Axelrad J. Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Vedolizumab or Ustekinumab. , Am J Gastroenterol, 647: 2019,114

Mujumdar S, Goldenberg J, Bieser S, Pang AS, Coben R. Cholestatic Liver Injury in a Patient with Tertiary Syphilis , Case Rep Gastroenterol, 16: 2022,552-556

Pang A, Zeineddine HA Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. , Cerebrovasc Dis., 43(5-6): 2017,223-230

Wood M, Rawe M, Johansson G, Pang S, Soderquist R, Patel A, Nelson S, Seibel W, Ratner N, Sanchez Y. Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cell lines. , Mol Cancer Ther. , 10(9): 2011 ,1740-1750